Search Results

You searched for: "saftey of biosimilars"
Health
Biosimilars: Policy, Clinical, and Regulatory Considerations
Scott Gottlieb | American Journal of Health-System Pharmacy
July 15, 2008

The evolution of the European Union"s approach to regulating biosimilars is a potential model upon which we can design a process that facilitates access to biosimilars while providing assurances of safety.

PAGE:
AEI on Facebook